Top compounds associated with response to C1orf106


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC 0.35 2e-09
mRNA lapatinib gCSI pan-cancer AAC 0.33 9e-09
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.22 4e-08
mRNA lapatinib CTRPv2 pan-cancer AAC 0.22 5e-08
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.22 2e-07
mRNA niclosamide CTRPv2 pan-cancer AAC -0.21 2e-07
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.21 4e-07
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 4e-07
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-06
mRNA neratinib CTRPv2 pan-cancer AAC 0.19 1e-06
Download CSV